Magazine article Public Finance

MPs Criticise Nice for Failing to Evaluate Older Medicines

Magazine article Public Finance

MPs Criticise Nice for Failing to Evaluate Older Medicines

Article excerpt

The National Institute for Health and Clinical Effectiveness has been criticised for failing to evaluate older medicines that might not be providing value for money.

Senior MPs said it was 'unacceptable' that Nice had ignored repeated recommendations to scrutinise older medicines that might do no good and might not be cost-effective.

In a report published on January 10, the health select committee said more should be done to encourage this 'disinvestment'. It noted that no Nice evaluation of older therapies was yet complete, but two were under way.

David Stout director ofthe NHS Confederation's Primary Care Trust Network, said: 'It is important that disinvestment becomes an increasing priority for Nice, and that older treatments are reviewed to ensure PCTs can provide the most cost-effective care to patients, as highlighted in our evidence to the committee.

'However, we must be careful not to overestimate the scale of saving that could be made in the NHS. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.